Progression of chronic kidney disease in non- dialysis patients: a retrospective cohort
Aquino, Jéssica Azevedo; Oliveira, Cláudia Lorenzo; Otoni, Alba; Sanches, Cristina; Guedes, João Victor Marques; Morais, Diego Bruno; Mendonça, Thays Santos; Morais, Flávio Augusto; Baldoni, André Oliveira.
Braz. J. Pharm. Sci. (Online)
; 58: e20249, 2022. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-1403728
Abstract Evidence on factors associated with the progression of chronic kidney disease (CKD) is still under construction. The present study aimed to evaluate sociodemographic, clinical, and drug use factors associated with the progression of CKD. A retrospective cohort study was conducted with 193 patients with CKD stages 3A to 5- non-dialysis followed for three years in a Brazilian city. The outcome was the evolution to renal replacement therapy (RRT) or death. A total of 52.3 % (n = 101) were men and 83.4 % (n = 161) elderly. The median age was 72.0 years, and 22.3 % (n = 44) progressed to RRT or death, and the three-year mortality rate was 20.2 %. Participants exposed to angiotensin converting enzyme inhibitors or angiotensin II receptor blockers had a lower risk of progressing to the outcome (hazard ratio (HR) 0.25; p = 0.003) and higher survival (p = 0.022) when compared to those not exposed to these drugs. Age (HR 1.06;) and use of omeprazole (HR 6.25; CI; p <0.01) and hydrochlorothiazide (HR 2.80; p = 0.028) increased the risks of RRT or death. The results highlight the importance of rational management of pharmacotherapy for patients with CKD
Biblioteca responsable:
BR40.1
Ubicación: BR40.1
Texto completo
Documentos relacionados